MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
$4,337,820
EPS
$0.07
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
General and administrative costs
132,030 21,846 155,513
Total operating expenses
132,030 21,846 -
Loss from operations
-132,030 -21,846* -155,513
Interest earned on cash and investments held in trust account
4,439,850 4,411,961.25* 109,355
Gain on extinguishment of over-allotment option liability
-138,437* -
Provision for credit losses
-203,028.25* -
Recovery of credit losses
-30,000 --
Total other income
4,469,850 4,347,370* 109,355
Net income (loss)
4,337,820 4,325,524 -46,158
Basic EPS
0.07 0.181 0
Diluted EPS
0.07 0.181 0
Basic Average Shares
50,000,000 23,857,951 2,717,391
Diluted Average Shares
50,000,000 23,857,951 2,717,391
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest earned on cashand investments...$4,439,850 Recovery of credit losses-$30,000 Total other income$4,469,850 Net income (loss)$4,337,820 Loss from operations-$132,030 Total operatingexpenses$132,030 General andadministrative costs$132,030

Drugs Made In America Acquisition II Corp. (DMII)

Drugs Made In America Acquisition II Corp. (DMII)